Patents Represented by Attorney, Agent or Law Firm Mathews, Collins Sherpherd & Gould
  • Patent number: 6281230
    Abstract: Substituted 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are useful in treating inflammation, inflammatory disease, autoimmune disease, and oncogenic or cancerous conditions in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline and 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: August 28, 2001
    Assignee: Celgene Corporation
    Inventors: George W. Muller, David I. Stirling, Roger Shen-Chu Chen
  • Patent number: 6071165
    Abstract: In accordance with the invention, a hollow, gas-containing diving body is disposed in a partially shaded transparent column partially-filled with a clear liquid. The diver is weighted for near-neutral buoyancy. The upper portion of the column is shaded, and the lower portion is subjected to thermal radiation such as sunlight. When radiation strikes the diver, it heats the gas, thereby increasing the gas volume, displacing liquid and increasing the buoyancy of the diver. The diver therefore rises to the shaded region where the gas cools, causing the diver to sink. The cycle repeats.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: June 6, 2000
    Inventor: Greg E. Blonder